Trial Profile
Phase 2b study of ATX-MS-1467 in patients with multiple sclerosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs WP 1303 Worg Pharmaceuticals (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 23 Feb 2017 New trial record